3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Parkinsonian Disorders in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (70.59) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forsgren, L; Holmberg, H; Jakobson Mo, S; Larsson, A; Linder, J; Riklund, K | 1 |
Antke, C; Beu, M; Dinkelbach, L; Ferrea, S; Hammesfahr, S; Mamlins, E; Moldovan, AS; Müller, HW; Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
Cheng, CA; Hsueh, CJ; Huang, WS; Lee, JT; Lin, CC; Peng, GS; Wu, YC | 1 |
Afzal, W; Apostolova, I; Buchert, R; Buhmann, C; Derlin, T; Hesse, S; Klutmann, S; Meyer, PT; Wilke, F | 1 |
Hattori, N; Li, Y; Motoi, Y; Nakanishi, A; Ogaki, K; Shimizu, N; Takanashi, M; Tomiyama, H; Yokoyama, K | 1 |
Antke, C; Beu, M; Müller, HW; Nikolaus, S; Schnitzler, A; Südmeyer, M; Wojtecki, L; Zizek, T | 1 |
Buhmann, C; Bussopulos, A; Oechsner, M | 1 |
Hwang, WJ; Ting, G; Wey, SP; Yao, WJ | 1 |
Awad, AG; Voruganti, LP | 1 |
Amthauer, H; Arnold, G; Felix, R; Klaffke, S; Kühn, A; Kupsch, A; Lüdemann, L; Plotkin, M; Venz, S; Wernecke, KD | 1 |
Boesch, SM; Donnemiller, E; Müller, J; Poewe, W; Seppi, K; Weirich-Schwaiger, H; Wenning, GK | 1 |
Battistin, L; Briani, C; Cagnin, A; Chierichetti, F; Pizzolato, G; Tiberio, M | 1 |
Barthel, H; Hesse, S; Oehlwein, C; Polster, D; Sabri, O; Schwarz, J; Wagner, A | 1 |
Amthauer, H; Felix, R; Harnack, D; Klaffke, S; Kuhn, AA; Kupsch, A; Plotkin, M | 1 |
Linke, R; Radau, PE; Slomka, PJ; Tatsch, K | 1 |
Barthel, H; Dietrich, J; Georgi, P; Hermann, W; Reuter, M; Wagner, A | 1 |
Chen, CH; Huang, WS; Lin, SZ; Liu, HW; Liu, JC; Ma, KH; Ting, G; Wang, SD; Wey, SP | 1 |
1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinsonian Disorders
Article | Year |
---|---|
Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Brain; Cognition Disorders; Contrast Media; Cross-Sectional Studies; Dopamine; Follow-Up Studies; Humans; Motivation; Nucleus Accumbens; Parkinsonian Disorders; Pyrrolidines; Schizophrenia; Time Factors; Tomography, Emission-Computed | 2004 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinsonian Disorders
Article | Year |
---|---|
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Benzamides; Diagnosis, Differential; Humans; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tropanes | 2011 |
15 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinsonian Disorders
Article | Year |
---|---|
Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.
Topics: Aged; Benzamides; Case-Control Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Follow-Up Studies; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Supranuclear Palsy, Progressive; Synapses; Time Factors; Tomography, Emission-Computed, Single-Photon | 2013 |
FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
Topics: Aged; Benzamides; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2016 |
(99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.
Topics: Benzamides; Dopamine; Female; Humans; Hyponatremia; Middle Aged; Myelinolysis, Central Pontine; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.
Topics: Benzamides; Diagnosis, Differential; Dopamine Antagonists; Fluorodeoxyglucose F18; Humans; Observer Variation; Parkinsonian Disorders; Patient Selection; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2010 |
Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with
Topics: Adult; Aged; Asparagine; Benzamides; Brain; Chromosomes, Human, Pair 17; Female; Hand Strength; Humans; Lysine; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Supranuclear Palsy, Progressive; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2011 |
Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease.
Topics: Atrophy; Basal Ganglia; Benzamides; Cerebellum; Contrast Media; Corpus Striatum; Dopamine Agonists; Humans; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Parkinsonian Disorders; Phenotype; Pons; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
Topics: Adult; Benzamides; Brain; Contrast Media; Diagnosis, Differential; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |
Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
Topics: Aged; Benzamides; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Receptors, Dopamine D2; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2005 |
Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
Topics: Adult; Basal Ganglia; Benzamides; Cerebellum; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dystonic Disorders; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Spinocerebellar Ataxias; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2004 |
Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.
Topics: Basal Ganglia; Benzamides; Brain Mapping; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Thiethylperazine; Tomography, Emission-Computed, Single-Photon | 2004 |
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
Topics: Aged; Antiparkinson Agents; Benzamides; Diagnosis, Differential; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
Topics: Aged; Benzamides; Blood Glucose; Brain; Cerebral Cortex; Cocaine; Corpus Striatum; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |
Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism.
Topics: Benzamides; Corpus Striatum; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Receptors, Dopamine D2; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2000 |
[Hallervorden-Spatz disease: findings in the nigrostriatal system].
Topics: Adolescent; Benzamides; Cocaine; Corpus Striatum; Diagnosis, Differential; Disease Progression; Dopamine Antagonists; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinsonian Disorders; Pyrrolidines; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2000 |
Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.
Topics: Animals; Benzamides; Brain; Dopamine; Macaca; Organotechnetium Compounds; Oxidopamine; Parkinsonian Disorders; Predictive Value of Tests; Pyrrolidines; Radiopharmaceuticals; Reference Values; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tropanes | 2002 |